HCW Biologics Says it Gets FDA Clearance for Phase 1 Trial of Cancer Drug Candidate; Shares Rise Pre-Bell
HCW Biologics Says it Gets FDA Clearance for Phase 1 Trial of Cancer Drug Candidate; Shares Rise Pre-Bell
HCW Biologics表示已获得美国食品药品管理局批准抗癌药物候选药物的1期试验;股价在收盘前上涨
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册